Albright, B., Wallbillich, J., Lightfoot, M., Mattei, L., Polan, R., Kailasam, A., … Ko, E. (2024). Estimating the population-level impact of a platinum chemotherapy shortage on patients with gynecologic cancers in the United States cost-effectiveness of investing in the supply chain. In Gynecologic Oncology (Vol. 190, pp. S340–S341). Elsevier BV. https://doi.org/10.1016/j.ygyno.2024.07.510

Albright, Benjamin, John Wallbillich, Michelle Lightfoot, Larissa Mattei, Rosa Polan, Aparna Kailasam, Emeline Aviki, et al. “Estimating the population-level impact of a platinum chemotherapy shortage on patients with gynecologic cancers in the United States cost-effectiveness of investing in the supply chain.” In Gynecologic Oncology, 190:S340–41. Elsevier BV, 2024. https://doi.org/10.1016/j.ygyno.2024.07.510.

Albright B, Wallbillich J, Lightfoot M, Mattei L, Polan R, Kailasam A, et al. Estimating the population-level impact of a platinum chemotherapy shortage on patients with gynecologic cancers in the United States cost-effectiveness of investing in the supply chain. In: Gynecologic Oncology. Elsevier BV; 2024. p. S340–1.

Albright, Benjamin, et al. “Estimating the population-level impact of a platinum chemotherapy shortage on patients with gynecologic cancers in the United States cost-effectiveness of investing in the supply chain.” Gynecologic Oncology, vol. 190, Elsevier BV, 2024, pp. S340–41. Crossref, doi:10.1016/j.ygyno.2024.07.510.

Albright B, Wallbillich J, Lightfoot M, Mattei L, Polan R, Kailasam A, Aviki E, Saiz A, Spencer R, Havrilesky L, Shahin M, Fader A, Secord AA, Myers E, Ko E. Estimating the population-level impact of a platinum chemotherapy shortage on patients with gynecologic cancers in the United States cost-effectiveness of investing in the supply chain. Gynecologic Oncology. Elsevier BV; 2024. p. S340–S341.